TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research September 13, 1996
TCL Archive Centers Form Big Ten Research Consortium with Access to Over 30,000 New Patients a Year May 31, 2013
